The University of Pennsylvania and Longfellow Real Estate Partners are planning to construct a 455,000-sf life sciences center on the Pennovation Works property in Philadelphia. Designed by Jacobs, the project will include three structures providing a total of 387,000 sf of R&D space and 68,000 sf of biomanufacturing space for the production of cell and gene therapies. Topped by green roof terraces, the main two-building complex will feature flexible lab and office environments for biomedical and pharmaceutical tenants. Longfellow will develop, finance, and operate the facilities under a 75-year ground lease. Construction will begin in 2023 with occupancy expected in late 2025.
Located across the Schuylkill River from the university's core campus, Pennovation Works was created through the adaptive reuse of an industrial estate previously occupied by DuPont. The site currently houses the Pennovation Center, an incubator for science and technology startups, with the 65,000-sf Pennovation Lab offering larger footprints for growing companies.